Record NNP B-NP O
date NN I-NP O
: : O O
2154-05-15 CD O B-DATE
Team NN B-NP O
3 CD I-NP O
Admission NN I-NP O
Note NN I-NP O
PATIENT NNP B-NP O
: : O O
Nathan NNP B-NP B-PATIENT
Ishida NNP I-NP I-PATIENT
MRN NNP B-NP O
: : O O
8792076 CD O B-MEDICALRECORD
ADMIT NNP B-NP O
DATE NNP I-NP O
: : O O
May NNP B-NP B-DATE
15 CD I-NP I-DATE
, , I-NP I-DATE
2154 CD O I-DATE
PCP NN B-NP O
: : O O
Norman NNP B-NP B-DOCTOR
Jewett NNP I-NP I-DOCTOR
, , O O
MD . O O
ATTENDING VBG B-NP O
PHYSICIAN NNP I-NP O
: : O O
CONTACT NN B-NP O
: : O O
Alice NNP B-NP B-PATIENT
Zacharias NNP I-NP I-PATIENT
, , O O
( -LRB- B-NP I-PHONE
582 CD I-NP I-PHONE
)157-6993 CD O I-PHONE
CODE NNP B-NP O
STATUS NNP I-NP O
: : O O
Full NNP B-NP O
CHIEF NNP B-NP O
COMPLAINT NNP I-NP O
Dizziness NNP B-NP O
and CC O O
change VB B-VP O
in IN B-PP O
mental JJ B-NP O
status NN I-NP O
HISTORY NN B-NP O
OF IN B-PP O
PRESENT JJ B-NP O
ILLNESS NNS I-NP O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
78 CD I-NP B-AGE
y/o NN I-NP O
, , O O
who WP B-NP O
p/w VBP B-VP O
dizziness NN B-NP O
that WDT B-NP O
began VBD B-VP O
2 CD B-NP O
to TO B-PP O
3 CD B-NP O
weeks NNS I-NP O
ago RB B-ADVP O
. . O O
The DT B-NP O
pt NN I-NP O
says VBZ B-VP O
the DT B-NP O
dizziness NN I-NP O
was VBD B-VP O
worsened VBN I-VP O
when WRB B-ADVP O
he PRP B-NP O
stood VBD B-VP O
up RB B-ADVP O
to TO B-VP O
walk VB I-VP O
around RB B-ADVP O
; : O O
noting VBG B-VP O
that IN B-SBAR O
it PRP B-NP O
was VBD B-VP O
particularly RB B-ADJP O
bad JJ I-ADJP O
when WRB B-ADVP O
he PRP B-NP O
was VBD B-VP O
standing VBG I-VP O
and CC I-VP O
concentrating VBG I-VP O
on IN B-PP O
a DT B-NP O
particular JJ I-NP O
task NN I-NP O
such JJ B-PP O
as IN I-PP O
shaving NN B-NP O
. . O O
The DT B-NP O
dizziness NN I-NP O
was VBD B-VP O
alleviated VBN I-VP O
by IN B-PP O
him PRP B-NP O
lying VBG B-VP O
down RB B-ADVP O
. . O O
He PRP B-NP O
added VBD B-VP O
that IN B-SBAR O
he PRP B-NP O
began VBD B-VP O
feeling VBG I-VP O
dizzy JJ B-ADJP O
during IN B-PP O
the DT B-NP O
storm NN I-NP O
last JJ B-NP O
week NN I-NP O
when WRB B-ADVP O
his PRP$ B-NP O
drinking NN I-NP O
water NN I-NP O
was VBD B-VP O
contaminated VBN I-VP O
. . O O
He PRP B-NP O
drank VBD B-VP O
tap NN B-NP O
water NN I-NP O
until IN B-SBAR O
he PRP B-NP O
was VBD B-VP O
told VBN I-VP O
it PRP B-NP O
was VBD B-VP O
undrinkable JJ B-ADJP O
, , O O
then RB B-ADVP O
he PRP B-NP O
stopped VBD B-VP O
. . I-VP O
He PRP B-NP O
later RB B-ADVP O
developed VBD B-VP O
diarrhea NN B-NP O
while IN B-SBAR O
not RB O O
drinking VBG B-VP O
any DT B-NP O
water NN I-NP O
and CC O O
only RB B-VP O
having VBG I-VP O
occasional JJ B-NP O
Coca-cola NNP I-NP O
beverages NNS I-NP O
. . O O
During IN B-PP O
these DT B-NP O
2 CD I-NP O
weeks NNS I-NP O
of IN B-PP O
dizziness NN B-NP O
, , O O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
notes VBZ B-VP O
he PRP B-NP O
felt VBD B-VP O
that IN B-SBAR O
he PRP B-NP O
lost VBD B-VP O
3-4 CD B-NP O
days NNS I-NP O
of IN B-PP O
his PRP$ B-NP O
life NN I-NP O
, , O O
saying VBG B-VP O
that IN B-SBAR O
he PRP B-NP O
was VBD B-VP O
either RB I-VP O
knocked VBN I-VP O
out RP B-NP O
or CC I-NP O
unconscious JJ I-NP O
. . O O
He PRP B-NP O
came VBD B-VP O
to TO B-PP O
this DT B-NP O
conclusion NN I-NP O
b/c IN B-PP O
his PRP$ B-NP O
medication NN I-NP O
box NN I-NP O
was VBD B-VP O
still RB B-ADVP O
full JJ B-ADJP O
for IN B-PP O
the DT B-NP O
previous JJ I-NP O
3 CD I-NP O
days NNS I-NP O
; : O O
supporting VBG B-VP O
his PRP$ B-NP O
reflection NN I-NP O
by IN B-PP O
saying VBG B-VP O
he PRP B-NP O
rarely RB B-ADVP O
ever RB B-ADVP O
misses VBZ B-VP O
his PRP$ B-NP O
medication NN I-NP O
. . O O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
states VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
room NN I-NP O
was VBD B-VP O
not RB I-VP O
spinning VBG I-VP O
and CC O O
said VBD B-VP O
that IN O O
his PRP$ B-NP O
dizziness NN I-NP O
was VBD B-VP O
more JJR B-ADJP O
like IN B-PP O
&#8220;lightheadness NN B-NP O
.&#8221 NN I-NP O
; : O O
He PRP B-NP O
feels VBZ B-VP O
that IN B-SBAR O
his PRP$ B-NP O
problems NNS I-NP O
began VBD B-VP O
when WRB I-VP O
taking VBG I-VP O
Tylenol- NNP B-NP O
2 CD B-NP O
weeks NNS I-NP O
ago RB B-ADVP O
and CC O O
cannot RB B-VP O
identify VB I-VP O
any DT B-NP O
other JJ I-NP O
medication NN I-NP O
that WDT B-NP O
is VBZ B-VP O
associated VBN I-VP O
with IN B-PP O
his PRP$ B-NP O
symptoms NNS I-NP O
. . O O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
says VBZ B-VP O
he&#8217 PRP B-NP O
;s VBZ B-VP O
never RB I-VP O
experienced VBN I-VP O
any DT B-NP O
dizziness NN I-NP O
before IN I-NP O
, , O O
and CC O O
hoped VBD B-VP O
his PRP$ B-NP O
symptoms NNS I-NP O
would MD B-VP O
subside VB I-VP O
if IN B-SBAR O
he PRP B-NP O
just RB B-VP O
stayed VBD I-VP O
in IN B-PP O
bed NN B-NP O
. . O O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
also RB B-ADVP O
described VBD B-VP O
an DT B-NP O
increased JJ I-NP O
pressure NN I-NP O
in IN B-PP O
his PRP$ B-NP O
head NN I-NP O
, , O O
saying VBG B-VP O
, , O O
&#8220;it PRP B-NP O
felt VBD B-VP O
as IN B-SBAR O
if IN B-SBAR O
my PRP$ B-NP O
eyes NNS I-NP O
and CC I-NP O
ears NNS I-NP O
were VBD B-VP O
going VBG I-VP O
to TO I-VP O
explode VB I-VP O
.&#8221 CD B-NP O
; : O O
Pt NNP B-NP O
denies VBZ B-VP O
head NN B-NP O
trauma/falls NNS I-NP O
, , O O
syncope NN B-NP O
, , O O
intoxication IN B-PP O
( -LRB- B-NP O
from IN B-PP O
drugs NNS B-NP O
or CC O O
ETOH) NNP B-NP O
, , O O
or CC O O
CP. NNP B-NP O
REVIEW NN B-NP O
OF IN B-PP O
SYSTEMS NNP B-NP O
General NNP B-NP O
- : O O
No DT B-NP O
fatigue NN I-NP O
, , O O
lack NN B-NP O
of IN B-PP O
sleep NN B-NP O
, , O O
change NN B-NP O
in IN B-PP O
appetite NN B-NP O
, , O O
or CC O O
weight NN B-NP O
gain/loss NN I-NP O
Skin- NNP B-NP O
No DT B-NP O
rashes NNS I-NP O
, , O O
pruritus NN B-NP O
, , O O
bruising VBG B-VP O
, , O O
or CC O O
swelling VBG B-UCP O
Head NNP B-NP O
- : O O
No DT B-NP O
trauma NN I-NP O
, , I-NP O
headache NN I-NP O
or CC I-NP O
syncope NN I-NP O
Eyes NNS B-NP O
- : O O
No DT B-NP O
change NN I-NP O
in IN B-PP O
vision NN B-NP O
, , I-NP O
blurring NN I-NP O
, , I-NP O
diplopia NN I-NP O
, , I-NP O
irritation NN I-NP O
, , I-NP O
photophobia NN I-NP O
, , I-NP O
discharge NN I-NP O
, , O O
or CC O O
spots/flashes NNS B-NP O
Ears NNS B-NP O
- : O O
No DT B-NP O
change NN I-NP O
in IN B-PP O
hearing NN B-NP O
, , O O
pain NN B-NP O
, , O O
itching VBG B-VP O
, , O O
buzzing VBG B-NP O
, , O O
or CC O O
ringing VBG B-UCP O
Nose NNP B-NP O
- : O O
No DT B-NP O
nasal JJ I-NP O
congestion NN I-NP O
, , O O
runny JJ B-NP O
nose NN I-NP O
, , O O
or CC O O
epistaxis NNS B-NP O
Mouth/Throat- NNP B-NP O
No DT B-NP O
oral JJ I-NP O
ulcers NNS I-NP O
, , O O
pain NN B-NP O
, , O O
dry JJ B-NP O
mouth NN I-NP O
, , O O
dysphagia NN B-NP O
, , O O
sore JJ B-NP O
throat NN I-NP O
, , O O
or CC O O
swollen JJ B-NP O
glands NNS I-NP O
Neck NNP B-NP O
- : O O
No DT B-NP O
pain NN I-NP O
, , O O
discomfort NN B-NP O
Breast- NNP B-NP O
No DT B-NP O
pain NN I-NP O
, , O O
masses NNS B-NP O
, , O O
or CC O O
discharge NN B-NP O
Lungs NNP B-NP O
- : O O
No DT B-NP O
cough NN I-NP O
, , O O
SOB NNP B-NP O
, , O O
DOE NNP B-NP O
, , O O
orthopnea NN B-NP O
, , O O
PND NNP B-NP O
, , O O
or CC O O
pain NN B-NP O
Cardiac NNP B-NP O
- : O O
No DT B-NP O
CP CD I-NP O
or CC O O
pressure NN B-NP O
or CC I-NP O
palpitations NNS I-NP O
Abdomen- NNP B-NP O
Mild NNP I-NP O
occasional JJ I-NP O
constipation NN I-NP O
( -LRB- I-NP O
resolved VBN B-VP O
with IN B-PP O
laxative JJ B-NP O
or CC I-NP O
stool NN I-NP O
softener NN I-NP O
) -RRB- I-NP O
. . O O
No DT B-NP O
pain NN I-NP O
, , O O
cramping VBG B-VP O
, , O O
bloating VBG B-VP O
, , O O
indigestion NN B-NP O
, , O O
or CC O O
heartburn NN B-NP O
. . O O
GU- NNP B-NP O
No DT B-NP O
dysuria NN I-NP O
, , O O
polyuria NN B-NP O
, , O O
or CC O O
nocturia NN B-NP O
. . O O
No DT B-NP O
discharge NN I-NP O
or CC I-NP O
pain NN I-NP O
in IN B-PP O
penis NN B-NP O
or CC I-NP O
groin NN I-NP O
. . O O
MSK/Circulatory NNP B-NP O
: : O O
No DT B-NP O
arthralgias NNS I-NP O
, , O O
arthritis NN B-NP O
, , O O
cramps NNS B-NP O
, , O O
stiffness NN B-NP O
, , O O
myalgias NNS B-NP O
, , O O
tingling/numbness NN B-NP O
, , O O
or CC O O
claudications NNS B-NP O
Endo NNP B-NP O
- : O O
No DT B-NP O
heat/cold NN I-NP O
intolerance NN I-NP O
Neuro- NNP B-NP O
No DT B-NP O
shaking/tremors NNS I-NP O
, , O O
memory NN B-NP O
changes NNS I-NP O
, , O O
confusion NN B-NP O
, , O O
trouble NN B-NP O
reading NN I-NP O
, , O O
or CC O O
speech NN B-NP O
changes NNS I-NP O
. . O O
No DT B-NP O
paresthesias NN I-NP O
, , O O
numbness NN B-NP O
, , O O
or CC O O
weakness NN B-NP O
. . O O
Psych NNP B-NP O
- : O O
No DT B-NP O
depression NN I-NP O
or CC I-NP O
sad JJ I-NP O
mood NN I-NP O
. . O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NN I-NP O
Major NNP B-NP O
Illness/Surgeries NNPS I-NP O
- : O O
DM NNS B-NP O
, , O O
CKD NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
Psoriasis NNP B-NP O
, , O O
BPH NNP B-NP O
, , O O
GERD/Barrett&#8217 DT B-NP O
;s NN I-NP O
Esophagitis NN I-NP O
( -LRB- I-NP O
1/2151 CD I-NP B-DATE
) -RRB- I-NP O
, , I-NP O
Gout NNP I-NP O
, , I-NP O
Sleep VBP B-VP O
Apnea NNP B-NP O
, , O O
s/p JJ B-NP O
knee NN I-NP O
replacement NN I-NP O
surgery NN I-NP O
, , O O
cholecystectomy NN B-NP O
, , O O
appendectomy NN B-NP O
, , O O
tonsillectomy NN B-NP O
. . O O
Medications NNS B-NP O
1 LS O O
. . B-NP O
Acetylsalicylic NNP I-NP O
Acid NNP I-NP O
( -LRB- I-NP O
Aspirin NN I-NP O
) -RRB- I-NP O
81 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
2. . B-NP O
Allopurinol NNP I-NP O
300 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
3. . B-NP O
Ammonium NNP I-NP O
Lactate NNP I-NP O
12 CD I-NP O
% NN I-NP O
Cream NN I-NP O
( -LRB- I-NP O
Amlactin NNP I-NP O
12 CD I-NP O
% NN I-NP O
) -RRB- I-NP O
1 CD I-NP O
APPLICATION NN I-NP O
TOP NNP I-NP O
BID NNP I-NP O
4 CD B-LST O
. . O O
Atenolol NNP B-NP O
25 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
5 CD B-NP O
. . O O
Dovonex NNP O O
( -LRB- O O
Calcipotriene NNP B-NP O
0.005 CD I-NP O
% NN I-NP O
) -RRB- I-NP O
TOP NNP I-NP O
BID NNP I-NP O
prn NN I-NP O
6 CD B-NP O
. . O O
Darifenacin NNP B-NP O
Extended NNP I-NP O
Release NNP I-NP O
( -LRB- I-NP O
Enablex NNP I-NP O
) -RRB- I-NP O
15 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
7. . B-NP O
Docusate NNP I-NP O
Sodium NNP I-NP O
( -LRB- I-NP O
Colace NN I-NP O
) -RRB- I-NP O
100 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
TID NNP I-NP O
8. CD B-NP O
Finasteride NNP I-NP O
( -LRB- I-NP O
Alopecia NNP I-NP O
) -RRB- I-NP O
( -LRB- I-NP O
Proscar NN I-NP O
) -RRB- I-NP O
5 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
9 CD B-NP O
. . O O
Furosemide NNP O O
( -LRB- O O
Lasix NNP B-NP O
) -RRB- I-NP O
40 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
10 CD B-NP O
. . B-PP O
Lactulose NNP B-NP O
30 CD I-NP O
ML NNP I-NP O
PO NNP I-NP O
qD . O O
11 CD B-NP O
. . O O
Lisinopril NNP B-NP O
40 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
12 CD B-NP O
. . O O
Metformin NNP B-NP O
500 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
13 CD B-NP O
. . O O
Naproxen NNP B-NP O
375 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
prn NN I-NP O
toe NN I-NP O
pain NN I-NP O
14 CD B-NP O
. . O O
Omeprazole NNP B-NP O
20 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
15 CD B-LST O
. . O O
Sennosides '' O O
( -LRB- B-NP O
Senna NNP I-NP O
Tablets NNP I-NP O
) -RRB- I-NP O
2 CD I-NP O
TAB NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
16 CD B-NP O
. . O O
Simvastatin NNP B-NP O
20 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QHS . O O
17 CD B-NP O
. . O O
Valsartan NNP O O
( -LRB- O O
Diovan NNP B-NP O
) -RRB- I-NP O
320 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
Allergies NNP B-NP O
- : O O
NKDA NN B-NP O
Immunizations NNS B-NP O
- : O O
Up-to-date : O O
FAMILY NNP B-NP O
HISTORY NN I-NP O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
&#8217 VBD B-VP O
;s RB B-ADVP O
mother NN B-NP O
died VBD B-VP O
at IN B-PP O
90 CD B-NP B-AGE
y/o NN I-NP O
and CC O O
his PRP$ B-NP O
father NN I-NP O
at IN B-PP O
64 CD B-NP B-AGE
y/o NN I-NP O
due JJ B-ADJP O
to TO B-PP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
. . O O
The DT B-NP O
Pt NNP I-NP O
has VBZ B-VP O
4 CD B-NP O
brothers NNS I-NP O
, , O O
3 CD B-NP O
daughters NNS I-NP O
, , O O
and CC O O
2 CD B-NP O
sons NNS I-NP O
; : O O
all DT B-NP O
in IN B-PP O
good JJ B-NP O
health NN I-NP O
according VBG B-VP O
to TO B-PP O
the DT B-NP O
pt NN I-NP O
. . O O
SOCIAL JJ B-NP O
HISTORY NN I-NP O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
s VBZ B-VP O
is VBZ B-VP O
an DT B-NP O
Visual JJ I-NP B-PROFESSION
Artist NN I-NP I-PROFESSION
and CC O O
former JJ B-NP O
Exhibit NN I-NP B-PROFESSION
Designer NN I-NP I-PROFESSION
. . O O
He PRP B-NP O
served VBD B-VP O
in IN B-PP O
the DT B-NP B-ORGANIZATION
government NN I-NP I-ORGANIZATION
as IN B-PP O
a DT B-NP O
consultant NN I-NP B-PROFESSION
, , O O
and CC O O
denies VBZ B-VP O
any DT B-NP O
hazardous JJ I-NP O
environmental JJ I-NP O
exposures NNS I-NP O
. . O O
His PRP$ B-NP O
wife NN I-NP O
died VBD B-VP O
10 CD B-NP O
years NNS I-NP O
ago IN B-PP O
of IN B-PP O
ovarian JJ B-NP O
cancer NN I-NP O
and CC O O
dearly RB B-VP O
misses VBZ I-VP O
her PRP B-NP O
. . O O
Diet- NNP B-NP O
Mr. NNP I-NP O
Ishida NNP I-NP B-PATIENT
s VBZ B-VP O
describes VBZ I-VP O
his PRP$ B-NP O
diet NN I-NP O
as IN B-SBAR O
&#8220;not PRP B-NP O
as RB B-ADJP O
good JJ I-ADJP O
as IN B-SBAR O
it PRP B-NP O
should MD B-VP O
be VB I-VP O
.&#8221 CD B-NP O
; : O O
He PRP B-NP O
said VBD B-VP O
he PRP B-NP O
generally RB B-ADVP O
eats VBZ B-VP O
what WP B-NP O
he PRP B-NP O
wants VBZ B-VP O
, , O O
eats VBZ B-VP O
out RP B-PRT O
a DT B-NP O
lot NN I-NP O
and CC O O
says VBZ B-VP O
he PRP B-NP O
can MD B-VP O
eat VB I-VP O
a DT B-NP O
lot NN I-NP O
of IN B-PP O
&#8220 CD B-NP O
;junk NN I-NP O
food NN I-NP O
. . O O
&#8221 '' O O
; : O O
He PRP B-NP O
also RB B-ADVP O
said VBD B-VP O
the DT B-NP O
only JJ I-NP O
time NN I-NP O
he PRP B-NP O
eats VBZ B-VP O
&#8220;well&#8221 CD B-NP O
; : O O
is VBZ B-VP O
when WRB B-ADVP O
he PRP B-NP O
eat VB B-VP O
at IN B-PP O
his PRP$ B-NP O
son&#8217 NN I-NP O
;s NNS I-NP O
or CC O O
daughter NN B-NP O
&#8217 IN B-PP O
;s NNP B-NP O
house NN I-NP O
. . O O
Smoking- NNP B-NP O
Non-smoker NN I-NP O
Alcohol- NNP B-NP O
2-3 CD I-NP O
bottles NNS I-NP O
of IN B-PP O
beer NN B-NP O
per IN B-PP O
month NN B-NP O
. . O O
Pt NNP O O
does VBZ O O
n&#8217;t PRP B-NP O
feel VB B-VP O
he PRP B-NP O
needs VBZ B-VP O
to TO I-VP O
cut VB I-VP O
back RB B-ADVP O
. . O O
Drugs NNS B-NP O
- : O O
According VBG B-VP O
to TO B-PP O
the DT B-NP O
pt NN I-NP O
he PRP B-NP O
has VBZ B-VP O
used VBN I-VP O
cocaine NN B-NP O
and CC I-NP O
crack NN I-NP O
as IN B-PP O
recent JJ B-NP O
5-6 CD I-NP O
years NNS I-NP O
ago RB B-ADVP O
. . O O
Sexual JJ B-NP O
Hx NNP I-NP O
- : O O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
s VBZ B-VP O
is VBZ B-VP O
not RB O O
currently RB B-ADVP O
sexually RB B-ADJP O
active JJ I-ADJP O
. . O O
PHYSICAL NNP B-NP O
EXAM NNPS I-NP O
Pt NNP B-NP O
is VBZ B-VP O
an DT B-NP O
obese JJ I-NP O
man NN I-NP O
with IN B-PP O
noticeable JJ B-NP O
skin NN I-NP O
lesions NNS I-NP O
( -LRB- B-PP O
psoriasis NN B-NP O
) -RRB- I-NP O
and CC O O
alopecia DT B-NP O
. . O O
He PRP B-NP O
looks VBZ B-VP O
well RB B-ADVP O
and CC O O
jovial JJ B-VP O
aside RB B-ADVP O
from IN B-PP O
his PRP$ B-NP O
labored JJ I-NP O
breathing NN I-NP O
. . O O
VS NNP B-NP O
: : O O
T NNP B-NP O
: : O O
97.8 CD B-NP O
BP NNP I-NP O
: : O O
122/60 CD B-NP O
HR NN I-NP O
: : O O
92 CD B-NP O
RR NN I-NP O
: : O O
18 CD B-NP O
SpO2 NN I-NP O
: : O O
97 CD B-NP O
on IN B-PP O
Room NNP B-NP O
Air NNP I-NP O
General NNP B-NP O
- : O O
No DT B-NP O
Acute NN I-NP O
Distress NN I-NP O
HEENT NNP B-NP O
- : O O
normocephalic JJ B-NP O
, , I-NP O
atraumatic JJ I-NP O
; : I-NP O
PERR NN I-NP O
, , O O
EOMI NNP B-NP O
, , O O
sclerae NN B-NP O
anicteric NN I-NP O
, , O O
no DT B-NP O
conjunctival NN I-NP O
injection NN I-NP O
; : O O
poor JJ B-NP O
dentition NN I-NP O
, , O O
oropharynx NNP B-NP O
pink JJ I-NP O
and CC I-NP O
moist JJ I-NP O
w/o NN I-NP O
erythema NN I-NP O
, , O O
exudates NNS B-NP O
, , O O
or CC O O
lesions NNS B-NP O
Neck NNP B-NP O
- : O O
no DT B-NP O
lymphadenopathy NN I-NP O
, , O O
normal JJ B-NP O
thyroid NN I-NP O
without IN B-PP O
masses NNS B-NP O
; : O O
JVP JJ B-NP O
flat JJ I-NP O
; : O O
carotid JJ B-NP O
pulses NNS I-NP O
2+ VBP B-VP O
bilaterally RB B-ADVP O
; : O O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
; : O O
the DT B-NP O
trachea NN I-NP O
is VBZ B-VP O
midline NN O O
Pulmonary JJ B-NP O
&#8211 CD I-NP O
; : O O
Symmetrical JJ B-NP O
expansion NN I-NP O
. . O O
Normal JJ B-NP O
percussion NN I-NP O
w/ VBD B-VP O
no DT B-NP O
change NN I-NP O
in IN B-PP O
fremitus NN B-NP O
. . B-NP O
Ronchi NNP I-NP O
and CC O O
wheezes NNS B-NP O
bilaterally RB B-ADVP O
. . O O
No DT B-NP O
egophony NN I-NP O
or CC I-NP O
pectoriloquy NN I-NP O
. . O O
Cardiac NNP B-NP O
&#8211 CD I-NP O
; : O O
irregularly RB B-NP O
irregular JJ I-NP O
rhythm NN I-NP O
and CC I-NP O
rate NN I-NP O
; : O O
S1 NNP B-NP O
and CC I-NP O
S2 NNP I-NP O
normal JJ I-NP O
; : O O
no DT B-NP O
murmurs NNS I-NP O
, , I-NP O
rubs NNS I-NP O
or CC I-NP O
gallops NNS I-NP O
; : O O
2+ CD B-NP O
pulses NNS I-NP O
in IN B-PP O
the DT B-NP O
extremities NNS I-NP O
bilaterally RB B-LST O
Abdomen NNP B-NP O
- : O O
soft JJ B-NP O
, , I-NP O
non-distended JJ I-NP O
; : O O
slight JJ B-NP O
tenderness NN I-NP O
upon IN B-PP O
palpation NN B-NP O
of IN B-PP O
posterior JJ B-NP O
abdomen NN I-NP O
; : O O
normal JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
; : O O
no DT B-NP O
masses NNS I-NP O
or CC I-NP O
hepatosplenomegaly NN I-NP O
Extremity NN B-NP O
- : O O
warm JJ B-NP O
and CC I-NP O
well-perfused JJ I-NP O
; : O O
no DT B-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
, , O O
or CC O O
edema NN B-NP O
Neurology NNP B-NP O
- : O O
CN NNP B-NP O
II-XII NNP I-NP O
grossly RB I-NP O
intact JJ I-NP O
, , I-NP O
good JJ I-NP O
strength NN I-NP O
bilaterally RB B-ADVP O
, , O O
normal JJ B-NP O
sensation NN I-NP O
bilaterally RB B-ADVP O
. . O O
Normal JJ B-NP O
gait NN I-NP O
. . O O
Skin NNP B-NP O
&#8211 CD I-NP O
; : O O
psoriatic JJ B-NP O
lesions NNS I-NP O
on IN B-PP O
elbows NNS B-NP O
and CC O O
thorax(anterior JJ B-NP O
and CC I-NP O
posterior JJ I-NP O
) -RRB- I-NP O
. . O O
Mental JJ B-NP O
status NN I-NP O
- : O O
alert JJ B-NP O
and CC O O
oriented JJ B-ADJP O
to TO B-PP O
self NN B-NP O
, , I-NP O
time NN I-NP O
, , O O
and CC O O
place NN B-NP O
LABORATORIES NNS B-NP O
142 CD B-NP O
113 CD I-NP O
58 CD O O
-------------- NNS B-NP O
115 CD B-NP O
5.3 CD B-NP O
20.6 CD I-NP O
3.03 CD O O
CA NNP B-NP O
9.2 CD I-NP O
PHOS NNP B-NP O
3.1 CD I-NP O
MG NNP B-NP O
2.3( CD I-NP O
H) . O O
TBILI NNP B-NP O
0.4 CD I-NP O
DBILI NNP B-NP O
0.1 CD I-NP O
TP NNP B-NP O
7.1 CD I-NP O
ALB NNP B-NP O
4.1 CD I-NP O
GLOB NNP B-NP O
3.0( JJ I-NP O
T NNP I-NP O
) -RRB- O O
AMY NNP B-NP O
83 CD I-NP O
LIPS NNP B-NP O
115( CD I-NP O
H) . O O
WBC NN B-NP O
5.5 CD I-NP O
RBC NNP B-NP O
4.11( JJ I-NP O
L NNP I-NP O
) -RRB- O O
HGB NNP B-NP O
12.2( JJ I-NP O
L NNP I-NP O
) -RRB- O O
HCT NNP B-NP O
38.3( JJ I-NP O
L NNP I-NP O
) -RRB- O O
PLT NNP B-NP O
149( JJ I-NP O
L NNP I-NP O
) -RRB- O O
MCV NNP B-NP O
93 CD I-NP O
ALT/SGPT NNP B-NP O
7( JJ I-NP O
L NNP I-NP O
) -RRB- O O
AST/SGOT NNP B-NP O
9( JJ I-NP O
L NNP I-NP O
) -RRB- O O
ALKP NNP B-NP O
70 CD I-NP O
CK-MB NN B-NP O
Negative JJ I-NP O
TROP-I NN B-NP O
Negative JJ I-NP O
MICROBIOLOGY NN B-NP O
N/A . O O
RADIOLOGICAL NNP B-NP O
STUDIES NNS I-NP O
CXR NNP B-NP O
: : O O
No DT B-NP O
pneumonia NN I-NP O
or CC I-NP O
other JJ I-NP O
significant JJ I-NP O
change NN I-NP O
from IN B-PP O
11/26/52 CD B-NP B-DATE
. . O O
Head NNP B-NP O
CT NNP I-NP O
: : O O
No DT B-NP O
acute JJ I-NP O
intracranial JJ I-NP O
hemorrhage NN I-NP O
, , O O
mass NN B-NP O
lesion NN I-NP O
or CC O O
territorial JJ B-NP O
infarction NN I-NP O
identified VBN B-VP O
. . B-NP O
Chronic NNP I-NP O
infarctions NNS I-NP O
of IN B-PP O
the DT B-NP O
pons NNS I-NP O
and CC O O
right JJ B-NP O
frontal JJ I-NP O
operculum NN I-NP O
, , O O
unchanged JJ B-ADJP O
. . O O
EKG . O O
Irregularly RB B-ADVP O
irregular JJ B-NP O
rhythm NN I-NP O
, , O O
RBBB NNP B-NP O
, , O O
abnormal JJ B-NP O
ECG. NNP I-NP O
PR&lt NNP I-NP O
; : O O
200 CD B-NP O
ms NNS I-NP O
, , O O
QRS&lt RB B-ADVP O
; : O O
110 CD B-NP O
ms NNS I-NP O
, , O O
QTc&gt NNP B-NP O
;470 CD I-NP O
ASSESSMENT NNP B-NP O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
78 CD I-NP B-AGE
y/o NN I-NP O
M NNP I-NP O
with IN B-PP O
h/o JJ B-NP O
CKD NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
and CC O O
NIDDM NNP B-NP O
p/w VBD B-VP O
sustained VBN I-VP O
dizziness NN B-NP O
and CC O O
altered VBD B-VP O
mental JJ B-NP O
status NN I-NP O
. . O O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
is VBZ B-VP O
most RBS B-ADVP O
likely JJ I-ADVP O
currently RB B-ADVP O
in IN B-PP O
a DT B-NP O
volume NN I-NP O
depleted VBD B-VP O
stated VBN I-VP O
. . O O
He PRP B-NP O
had VBD B-VP O
diarrhea NN B-NP O
induced VBN B-VP O
by IN B-PP O
the DT B-NP O
contaminated JJ I-NP O
water NN I-NP O
from IN B-PP O
the DT B-NP O
storm NN I-NP O
and CC O O
only RB B-ADVP O
maintained VBD B-VP O
his PRP$ B-NP O
hydration NN I-NP O
with IN B-PP O
a DT B-NP O
meager JJ I-NP O
2 CD I-NP O
or CC O O
3 CD B-NP O
bottles NNS I-NP O
of IN B-PP O
Coca-cola NNP B-NP O
over IN B-PP O
several JJ B-NP O
days NNS I-NP O
. . O O
This DT O O
in IN B-PP O
combination NN B-NP O
with IN B-PP O
his PRP$ B-NP O
output NN I-NP O
of IN B-PP O
fluid NN B-NP O
from IN B-PP O
diarrhea NN B-NP O
, , O O
his PRP$ B-NP O
diuretic JJ I-NP O
medication NN I-NP O
, , O O
and CC O O
possible JJ B-NP O
osmotic JJ I-NP O
diuresis NN I-NP O
( -LRB- I-NP O
increased VBN I-NP O
serum NN I-NP O
glucose NN I-NP O
level NN I-NP O
from IN B-PP O
soda NN B-NP O
intake NN I-NP O
in IN B-PP O
a DT B-NP O
diabetic NN I-NP O
) -RRB- I-NP O
could MD B-VP O
have VB I-VP O
shifted VBN I-VP O
him PRP B-NP O
into IN B-PP O
hypovolemia NN B-NP O
. . O O
Thus RB O O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
might MD B-VP O
have VB I-VP O
decrease NN B-NP O
effective JJ I-NP O
arterial NN I-NP O
volume NN I-NP O
causing VBG B-VP O
his PRP$ B-NP O
BUN/Cr JJ I-NP O
ratio NN I-NP O
to TO B-VP O
be VB I-VP O
elevated VBN I-VP O
, , O O
indicating VBG B-VP O
a DT B-NP O
prerenal JJ I-NP O
process NN I-NP O
. . O O
Although IN B-PP O
BUN/Cr NNP B-NP O
ratio NN I-NP O
is VBZ B-VP O
not RB O O
&gt JJ B-NP O
;20 NN I-NP O
, , O O
we PRP B-NP O
can MD B-VP O
still RB I-VP O
assume VB I-VP O
that IN B-SBAR O
he PRP B-NP O
has VBZ B-VP O
prerenal JJ B-NP O
ARF NN I-NP O
considering VBG B-VP O
his PRP$ B-NP O
use NN I-NP O
of IN B-PP O
diuretics NNS B-NP O
and CC O O
h/o NN B-NP O
CKD IN B-PP O
which WDT B-NP O
can MD B-VP O
decrease VB I-VP O
the DT B-NP O
sensitivity NN I-NP O
of IN B-PP O
BUN/Cr NNP B-NP O
rations NNS I-NP O
and CC O O
FENa NNP B-NP O
for IN B-PP O
assessing VBG B-VP O
etiologies NNS B-NP O
of IN B-PP O
renal JJ B-NP O
failure NN I-NP O
. . O O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
additionally RB B-ADVP O
uses VBZ B-VP O
NSAIDs NNP B-NP O
( -LRB- I-NP O
e NN I-NP O
.g NN I-NP O
. . O O
Naproxen NNP B-NP O
) -RRB- I-NP O
, , O O
an DT B-NP O
ARB NN I-NP O
and CC O O
an DT B-NP O
ACEI NNP I-NP O
, , O O
all DT B-NP O
of IN B-PP O
which WDT B-NP O
are VBP B-VP O
associated VBN I-VP O
with IN B-PP O
decreased VBN B-NP O
intraglomerular JJ I-NP O
pressure NN I-NP O
and CC O O
renal JJ B-NP O
vasoconstriction NN I-NP O
which WDT B-NP O
can MD B-VP O
lead VB I-VP O
to TO B-PP O
prerenal JJ B-NP O
ARF. NN I-NP O
Intrinsic JJ B-NP O
ARF NN I-NP O
is VBZ B-VP O
less RBR B-ADJP O
likely JJ I-ADJP O
considering VBG B-VP O
he PRP B-NP O
is VBZ B-VP O
not RB I-VP O
using VBG I-VP O
any DT B-NP O
overtly RB I-NP O
nephrotoxic JJ I-NP O
drugs NNS I-NP O
( -LRB- B-NP O
e NN I-NP O
.g NN I-NP O
. . O O
amphotericin '' O O
, , O O
cisplatin NN B-NP O
, , O O
or CC O O
aminoglycosides NNS B-NP O
. . O O
Conversely NNP B-NP O
, , O O
he PRP B-NP O
is VBZ B-VP O
at IN B-PP O
an DT B-NP O
increased VBN I-NP O
risk NN I-NP O
of IN B-PP O
cholesterol NN B-NP O
emboli NNS I-NP O
given VBN B-VP O
his PRP$ B-NP O
h/o NN I-NP O
of IN B-PP O
hypercholesterolemia NN B-NP O
and CC I-NP O
vasculopathy NN I-NP O
. . O O
Lastly RB B-ADVP O
, , O O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
my PRP$ B-NP O
have VBP B-VP O
a DT B-NP O
postrenal JJ I-NP O
ARF NN I-NP O
etiology NN I-NP O
considering VBG B-VP O
his PRP$ B-NP O
h/o NN I-NP O
BPH NNP I-NP O
which WDT B-NP O
could MD B-VP O
lead VB I-VP O
to TO B-PP O
obstruction NN B-NP O
of IN B-PP O
the DT B-NP O
outflow NN I-NP O
tract NN I-NP O
leading VBG B-VP O
to TO B-PP O
increased JJ B-NP O
pressures NNS I-NP O
in IN B-PP O
the DT B-NP O
ureters NNS I-NP O
flowing VBG B-VP O
back RB B-ADVP O
up IN B-PRT O
into IN B-PP O
the DT B-NP O
kidneys NNS I-NP O
. . O O
Mr. NNP B-NP O
Ishida NNP I-NP B-PATIENT
&#8217 CC O O
;s NNP B-NP O
dizziness NN I-NP O
and CC O O
altered VBD B-VP O
mental JJ B-NP O
status NN I-NP O
are VBP B-VP O
both DT O O
explained VBN B-VP O
by IN B-PP O
ARF. NNP B-NP O
Additional JJ I-NP O
explanations NNS I-NP O
of IN B-PP O
altered VBN B-NP O
mental JJ I-NP O
status NN I-NP O
are VBP B-VP O
ruled VBN I-VP O
out RP B-NP O
via IN B-PP O
the DT B-NP O
history NN I-NP O
and CC O O
physical JJ B-NP O
including VBG I-NP O
intoxication NN I-NP O
, , O O
brain NN B-NP O
hemorrhagic NN I-NP O
, , O O
brain NN B-NP O
tumor NN I-NP O
, , O O
etc FW B-NP O
. . O O
PLAN NN B-NP O
# # B-NP O
) -RRB- I-NP O
Acture NNP I-NP O
Renal NNP I-NP O
Failure NN I-NP O
-Continue JJ B-NP O
fluids NNS I-NP O
and CC I-NP O
hydration NN I-NP O
: : O O
1L CD B-NP O
of IN B-PP O
IV NNP B-NP O
saline NN I-NP O
over IN B-PP O
the DT B-NP O
next JJ I-NP O
24 CD I-NP O
hrs NNS I-NP O
-D/c JJ B-NP O
naproxen JJ I-NP O
use NN I-NP O
. . O O
-Rule NN B-NP O
out IN B-PP O
Post-renal NNP B-NP O
etiology NN I-NP O
: : O O
use NN B-NP O
ultrasound NN I-NP O
to TO B-VP O
assess VB I-VP O
the DT B-NP O
size NN I-NP O
of IN B-PP O
the DT B-NP O
bladder NN I-NP O
and CC I-NP O
ureters NNS I-NP O
. . O O
If IN B-PP O
enlarged VBN B-NP O
bladder NN I-NP O
and CC I-NP O
ureters NNS I-NP O
are VBP B-VP O
found VBN I-VP O
the DT B-NP O
diagnosis NN I-NP O
is VBZ B-VP O
more RBR I-VP O
likely JJ B-NP O
postrenal JJ I-NP O
ARF NN I-NP O
due JJ B-ADJP O
to TO B-PP O
an DT B-NP O
enlarged JJ I-NP O
prostate NN I-NP O
. . O O
Thus RB O O
the DT B-NP O
patient NN I-NP O
should MD B-VP O
be VB I-VP O
assessed VBN I-VP O
by IN B-PP O
Urology NNP B-NP O
of IN B-PP O
possible JJ B-NP O
partial JJ I-NP O
prostatectomy NN I-NP O
. . O O
# # B-NP O
) -RRB- I-NP O
DM . O O
-Discontinue JJ B-NP O
metformin NN I-NP O
due JJ B-ADJP O
to TO B-PP O
possibility NN B-NP O
of IN B-PP O
metabolic JJ B-NP O
acidosis NN I-NP O
and CC I-NP O
hospital NN I-NP O
drug NN I-NP O
interactions NNS I-NP O
. . O O
# # B-NP O
) -RRB- O O
CAD NN O O
-Switch NN B-NP O
Atenlol NNP I-NP O
to TO B-VP O
metoprolol VB I-VP O
given VBN B-NP O
ARF NN I-NP O
# # B-NP O
) -RRB- I-NP O
HTN . O O
-Discontinue JJ B-NP O
lisinopril NN I-NP O
, , O O
valsartan NN B-NP O
, , O O
furosemide NN B-NP O
until IN B-SBAR O
pt&#8217 PRP B-NP O
;s VBD B-VP O
renal JJ B-NP O
condition NN I-NP O
improves VBZ B-VP O
. . O O
# # B-NP O
) -RRB- I-NP O
Gout . O O
-D/C JJ B-NP O
allopurinol NN I-NP O
until IN B-SBAR O
pt&#8217 PRP B-NP O
;s VBD B-VP O
renal JJ B-NP O
condition NN I-NP O
improves VBZ B-LST O
# # B-NP O
)Hypercholesterolemia NN I-NP O
-Continue JJ B-NP O
simvastatin NN I-NP O
as IN B-PP O
previously RB B-NP O
prescribed VBN I-NP O
( -LRB- I-NP O
Simvastatin NNP I-NP O
20 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QHS) . O O
# # B-NP O
) -RRB- I-NP O
Psoriasis . O O
-Continue JJ B-NP O
Ammonium NNP I-NP O
Lactate NNP I-NP O
12 CD I-NP O
% NN I-NP O
Cream NN I-NP O
and CC O O
Calcipotriene NNP B-NP O
0.005 CD I-NP O
% NN I-NP O
TOP NNP I-NP O
BID NNP I-NP O
prn NN I-NP O
# # B-NP O
)Benign JJ I-NP O
Prostate NNP I-NP O
Hypertrophy NNP I-NP O
-Continue JJ B-NP O
Finasteride NNP I-NP O
and CC I-NP O
darifenacin JJ I-NP O
as IN B-PP O
previously RB B-NP O
prescribed VBN I-NP O
. . O O
William NNP B-NP B-DOCTOR
Yates NNP I-NP I-DOCTOR
, , O O
MSIII NNP B-NP O
Pager NNP B-NP O
# # I-NP O
66612 CD O B-PHONE
